Lexeo Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Lexeo Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2022 to 2023.
  • Lexeo Therapeutics, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $520K, a 2.56% increase year-over-year.
  • Lexeo Therapeutics, Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $2.29M.
  • Lexeo Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $2.29M, a 122% increase from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.29M +$1.26M +122% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 $1.03M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.